Andréia Machado Cardoso is an expert in Biochemistry at Federal University of Fronteira Sul (Brazil). Andréia Machado Cardoso has authored 74 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 225 (community average: 125). How the SLR is computed.

LeadR Profile

Andréia Machado Cardoso Federal University of Fronteira Sul Brazil
225 ScienceLeadR Reputation 225
Network Map

Biochemistry

Subspecialties: Geriatrics - Endocrinology - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2012 - 2026

Source: PubMed

Federal University of Fronteira Sul

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 74

Citations

Citations: 1 678 1st author: 15 Last author: 19 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
GLP-1-Based Therapy in Type 1 Diabetes: Balancing Efficacy, Safety, and Patient Selection.
PMID 42946972 — diabetes mellitus, glucagon-like peptide 1, glucagon-like peptide-1 receptor, safety, insulin, liraglutide, body weight, obesity, therapeutics, diabetic ketoacidosis, diabetes mellitus, type 1, ketosis, semaglutide
Diabetes Obes Metab20260
Exercise attenuates hypertension-induced renal dysfunction alongside changes in purine metabolism and A2A and P2X7 receptor expression.
PMID 42937080 — adenosine deaminase, exercise, hypertension, creatinine, receptors, purinergic p1, serum, arginine, polymerase chain reaction, adenosine monophosphate, kidney, enzymes, receptors, purinergic, analysis of variance, receptors, purinergic p2x7, adenosine triphosphate, dna
J Hypertens20260
Pharmacological melatonin induces mitochondrial dysfunction and alters extracellular nucleotide metabolism and CD39/CD73 expression in human melanoma cells.
PMID 42900413 — cells, genes, 5'-nucleotidase, melatonin, melanoma, neoplasms, cell line
Purinergic Signal20260
THE AGING PURINOME: A PURINERGIC FRAMEWORK LINKING THE HALLMARKS OF AGING TO INFLAMMAGING.
PMID 42858859 — cells, receptors, purinergic p1, aging, communication, adenosine
Ageing Res Rev20260
Effects of different intensities of aerobic exercise on intestinal permeability and inflammatory response in older adults: Randomized clinical trial.
PMID 42372927 — cytokines, exercise, serum, aging
Exp Gerontol20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Effects of Smartphone based Treatment for Bipolar Disorder the Smart Bipolar
NCT04230421 — feedback, bipolar disorder, smartphone, therapeutics
N/ARecruiting2021

LeadR Networks

Main global connection map